Education and Training
- Fellow in Hematology-Oncology, Medicine, Duke University, 1996 - 1999
- Medical Resident, Medicine, Duke University, 1993 - 1996
- M.D., Duke University, 1993
Anders, C. K., S. A. Snyder, R. C. Barrier, W. Demark-Wahnefried, R. A. Welch, P. K. Marcom, H. S. Shaw, S. Y. Chui, and K. L. Blackwell. “Inhibin A and B as predictive markers for chemotherapy-induced premature ovarian failure (POF) among premenopausal women with early stage breast cancer (ESBC).” In Breast Cancer Research and Treatment, 94:S47–S47. SPRINGER, 2005.
Shaw, Heather S., Katherine B. Hobbs, David J. Kroll, and Victoria L. Seewaldt. “Delayed-type hypersensitivity reaction with iscador M given in combination with cytotoxic chemotherapy.” J Clin Oncol 22, no. 21 (November 1, 2004): 4432–34. https://doi.org/10.1200/JCO.2004.04.140.
Shaw, H. S., and D. J. Kroll. “The convergence of herb pharmacodynamics and herb-drug interactions on hemostasis.” Altern Ther Health Med 7, no. 6 (November 2001): 46–47.
Kroll, D. J., H. S. Shaw, M. E. Wall, and N. H. Oberlies. “Variability in St. John's wort formulations is an important consideration.” Altern Ther Health Med 7, no. 6 (November 2001): 21–22.
Maxwell, G. L., J. I. Risinger, H. Shaw, A. Alvarez, J. C. Barrett, P. A. Futreal, and A. Berchuck. “Mutations in the PTEN tumor suppressor gene in cervical carcinomas.” International Journal of Gynecological Cancer 8, no. 6 (December 1, 1998): 489–93. https://doi.org/10.1046/j.1525-1438.1998.98102.x.
Maxwell, G. L., J. I. Risinger, C. Gumbs, H. Shaw, R. C. Bentley, J. C. Barrett, A. Berchuck, and P. A. Futreal. “Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.” Cancer Res 58, no. 12 (June 15, 1998): 2500–2503.